Daejoo Inc. Overview
Daejoo Inc. is a 64-year-old Korean compound-feed manufacturer that has largely become a mid-priced cat-food brand owner. Its flagship Catsrang dry cat food, launched in 2006, was ranked the second-largest cat-food brand in Korea behind Royal Canin in Euromonitor's 2021 data. The company says Catsrang is the No. 1 online cat-food brand in Korea. Pet food now accounts for roughly 70% of feed revenue and is produced at a single, over-utilised plant in Janghang (Seocheon, South Chungcheong). Livestock feed is produced at a large, under-utilised plant in Incheon. Revenue has been about KRW 100 bn for four years. Margins have expanded sharply, with gross margin rising from 15.5% in FY2021 to 25.2% in FY2025. The balance sheet is net cash. The book value of the Incheon plant land alone (KRW 73.8 bn) exceeds the company's current market value. The share price has been driven largely by political "theme" trading rather than fundamentals.
What the company does. Daejoo manufactures and sells compound (mixed) feed. Its products include livestock feed for cattle, pigs, poultry, ducks, goats, deer and quail, and pet food for dogs and cats. Through a wholly owned subsidiary, Namjeon Mulsan (㈜남전물산), it also manufactures animal medicines (WiseReport company overview; Investing.com profile). Third-party profiles also list real-estate leasing and pet-equipment sales as ancillary activities (Investing.com; StockHub). DART-based segment data show these to be immaterial.
The company's own description (paraphrased from DART-based summaries, FY2025/Q1 2026). Daejoo describes itself as a feed specialist founded in 1962. Its Incheon plant makes livestock feed for chickens, cattle and pigs, and its Janghang plant in Seocheon makes pet food. Both plants run on HACCP-certified equipment, and the company says it invests continuously in production efficiency and quality control. In response to slowing growth in the compound-feed market, it is expanding into pet food. It cites growth in one-person households and pet ownership as the driver, and develops products segmented by pet type, body shape and sensitivity. Distribution runs through e-commerce, hypermarkets, dealers/agencies and veterinary clinics. The company notes that most raw materials are imported, which leaves results sensitive to exchange rates and crop conditions (ValueLine Q1 2026 summary of the business section; WiseReport).
Business model and revenue model. Revenue is essentially all product sales of manufactured feed; there is no material service, subscription or licensing revenue. DART-based segment mix for the nine months to 3Q FY2025 was Feed 99.35%, Animal medicines 6.76%, Can 0.18%, and intra-group eliminations −6.29% (StockHub/StockStalker summary of the 3Q FY2025 quarterly report). Butler classifies 100% of 2Q FY2026 revenue as compound feed. Within feed, the pet-food share has risen from about 50% in FY2018–FY2019 (IBK Securities, Dec 2019) to about 70% by 2026 (IB Tomato, 14 Sep 2026, citing DART).
Value-chain position. Daejoo is a mid-stream processor. It buys mostly imported grains and protein meals (corn, soybean meal, wheat by-products, and animal protein meals such as chicken and tuna meal per the Catsrang ingredient list on Costco Korea). It formulates and extrudes or pellets them, then sells through two very different downstream chains:
Livestock feed: sold to farms, dealers and agricultural channels, including the National Agricultural Cooperative Federation (NACF), per Investing.com's Japanese-language profile. This business has commodity economics and competes against large integrators and cooperatives.
Pet food: a branded consumer business (Catsrang, Olive, Dograng, Shake-it Cat) sold online (own mall, Gmarket official store), through warehouse clubs (Costco Korea lists Catsrang Vita+ 20 kg), hypermarkets, dealers and vet clinics.
Customer types and end-markets. Livestock producers (poultry, swine, beef and dairy cattle, minor species); consumer pet owners, with a particular skew toward multi-cat households and street-cat feeders (Euromonitor described Catsrang as popular as street-cat food, DailyVet, May 2022); veterinary channels (animal medicines via Namjeon Mulsan); and export distributors in 8+ countries (company release, June 2026).
Independent characterisation. Daejoo is best understood as a value-priced Korean cat-food brand with a legacy livestock-feed mill and a large urban land holding attached. The pet business carries the group economically. The 2018 Janghang expansion and the subsequent mix shift explain the climb in gross margin from roughly 15–16% to 25%. The livestock business looks like a shrinking, low-return operation running at about a quarter of capacity. The Incheon site's land value (KRW 73.8 bn book) appears to be the main reason the plant has not been closed (IB Tomato, Sep 2026). The equity's market behaviour since 2025 has been dominated by political-theme speculation (Sejong relocation; the Seoul mayoral candidacy of Jung Won-oh) unrelated to operations.
Strategy
Stated strategy themes (from DART business-section summaries, FY2025/Q1 2026, paraphrased):
-
Shift from livestock feed to pet food. The company frames this as a response to slowing compound-feed growth and the rise in pet ownership driven by demographic change.
-
Premiumisation and segmentation. Developing high-quality pet food tailored to pet type, body shape and sensitivity, and expanding the share of premium products.
-
Quality infrastructure. HACCP-based plants and continuous investment in equipment and quality control.
-
Omnichannel distribution. E-commerce, hypermarkets, dealers and vet clinics.
Initiatives in the last 24 months (Oct 2024–Oct 2026):
Not publicly disclosed: medium-term financial targets, capex plans, capacity expansion at Janghang, ESG commitments, cost programmes, and any plan for the Incheon site. IB Tomato reported that the company did not respond to questions on restructuring, the equipment disposals or its revenue strategy (Sep 2026).
Analytical observation. The stated strategy points to more pet-food capacity, but none has been announced. Janghang has run above nameplate since at least 2016, even after the 2018 expansion. This is the main capacity gap in the strategy and the main capital-allocation question for the company.
Products & Services
Pet food — cat (Catsrang family; produced at Janghang)
| Product | Description and key specifications | Target | Launch / latest version | Pricing (where observed) | Source |
|---|---|---|---|---|---|
| Catsrang (classic) All-Life-Stage | Core dry cat food; 20 kg bulk format | All ages; multi-cat and street-cat feeders | Brand launched 2006 | — | Gmarket official store; Euromonitor via DailyVet |
| Catsrang Vita+ (비타플러스) All-Life-Stage | Vitamin-fortified premium version. 80%+ animal protein sources; three essential amino acids enhanced by 30%+; immune-supporting vitamins +10%; triangular kibble; "9-free" (no nine artificial additives). Registered analysis: crude protein ≥32%, crude fat ≥12%, moisture ≤10%, ash ≤10%, fibre ≤3.5%, Ca ≥0.8%, P ≥0.6%. Main ingredients: chicken meal, corn, tuna meal, chicken fat, vegetable proteins, beet pulp, flaxseed, brewer's yeast, plus amino acids, taurine, propolis, MRF, FOS and chelated minerals. 5 kg, 16 kg and 20 kg packs | All ages | Current range | Costco Korea: KRW 235 per 100 g (20 kg) | Costco Korea product #673612; Gmarket |
| Catsrang Kitten | Growth formula for kittens aged 1–12 months; 1,000 mg/kg New Zealand colostrum; five multivitamins | Kittens | Renewed Jan 2026 (Discovery News); re-promoted Jun 2026 | — | Company release, Taipei Pets Show, 24 Jun 2026 |
| Catsrang Kitten & Junior | Growth formula for cats from 2 months to under 4 years; protein and energy recipe with 90% animal protein sources. 2 kg and 8 kg | Young cats | Renewed 2026 | — | Company release, 24 Jun 2026; Gmarket |
| Catsrang Adult Weight Care | New low-fat recipe with about 35% less fat than Catsrang Adult; 300 mg/kg L-carnitine; 500 mg/kg CLA; animal-protein base. 6 kg | Adult and senior cats needing weight control | New in 2026 renewal | — | Company release, 24 Jun 2026; Gmarket |
| Catsrang Libre (리브레) All-Life-Stage | Dry cat food line; 5 kg and 18 kg | All ages | — | Gmarket price n/d | Gmarket official store |
| Catsrang Saengsaeng Chicken Indoor (생생닭고기 인도어) | Indoor-cat dry recipe with chicken; 5 kg | Indoor cats | — | — | Gmarket official store |
| Catsrang Gourmet Dish (고메디쉬) | Wet snack can for all life stages: tuna base with toppings, larger can than before; designed with gut, hairball and urinary health in mind. 160 g cans in 24-packs | All ages | Renewed 2026 | — | Company release, 24 Jun 2026; Gmarket |
| Catsrang Jeoyo-Jeoyo (저요저요) dental treats | Cat dental biscuits in salmon, chicken, tuna and lamb flavours; 60 g and 150 g | All ages | — | — | Gmarket official store |
| Catsrang Mom & Baby (맘앤베이비) | Life-stage line for pregnant/nursing cats and kittens | Queens and kittens | 2,020 | — | eToday, 2020 |
| Shake-it Cat (쉨잇 캣) | Freeze-dried cat food in four variants; 1.2 kg and 3 kg | Premium cat segment | — | — | Gmarket official store |
Pet food — dog
| Product | Description | Target | Launch / version | Pricing (observed) | Source |
|---|---|---|---|---|---|
| Olive Curcumin Joint Care (올리브 커큐민 관절 케어) | Functional dog food for joint care; 3 kg | Adult and senior dogs | Listed as new | List KRW 28,000; promotional KRW 21,800 | Gmarket official store |
| Olive Colostrum DHA Growth Care (올리브 초유DHA 성장 케어) | Growth formula with colostrum and DHA; 3 kg | Puppies | Listed as new | List KRW 28,000; promotional KRW 21,800 | Gmarket |
| Olive Hydrolyzed Low-Fat Digestive Care | Hydrolysed protein, low-fat digestive formula; 3 kg | Sensitive dogs | Listed as new | List KRW 28,000; promotional KRW 21,800 | Gmarket |
| Olive Hypoallergenic Skin & Coat Care | Hypoallergenic skin and coat formula; 3 kg | Allergy-prone dogs | Listed as new | List KRW 28,000; promotional KRW 21,800 | Gmarket |
| Olive Family (Lamb & Rice / Chicken & Rice / Salmon & Rice) | Probiotic dog food; 2 kg | All dogs | — | List KRW 12,900; promotional KRW 10,970 | Gmarket |
| Olive Balance / Olive Care Gut-Health Recipe | All-life-stage probiotic dog food; 6 kg | All dogs | — | — | Gmarket |
| Dograng Classic Bronze (도그랑 클래식 브론즈) | All-life-stage value dog food; 5 kg | Price-sensitive owners | — | — | Gmarket |
Livestock compound feed (produced at Incheon)
| Product line | Description | Target | Source |
|---|---|---|---|
| Cattle feed (beef and dairy) | Compound feed for cows | Cattle farms | Investing.com profile; WiseReport |
| Swine feed | Compound feed for pigs | Pig farms | Investing.com; WiseReport |
| Poultry feed (chicken, duck, quail) | Compound feed for layers, broilers, ducks, quail | Poultry farms | Investing.com |
| Minor-species feed (goat, deer) | Specialty compound feed | Small ruminant and deer farms | Investing.com |
Individual livestock-feed SKUs and brand names are n/d in accessed sources. Sales channels include distributors/agencies, NACF, retail stores and discount stores (Investing.com Japanese profile).
Other
| Offering | Description | Source |
|---|---|---|
| Animal medicines (Namjeon Mulsan) | Veterinary pharmaceuticals; 6.76% of 9M FY2025 revenue before eliminations | StockStalker summary of 3Q FY2025 report |
| Cans | 0.18% of revenue; contents not specified | Same |
| Real-estate leasing / pet equipment | Listed in third-party profiles; not separately disclosed | Investing.com; StockHub |
Brand positioning. Catsrang was described by Euromonitor (via DailyVet, 2022) as popular with street-cat feeders, a value and volume positioning. The 2025–2026 Vita+, Weight Care, Kitten and freeze-dried launches indicate a move up-market. The dog-food range (Olive functional line) is newer and smaller; no market-share data for it were found.
Financial Narrative
All income-statement data are consolidated, K-IFRS, from DART annual reports as republished by ETF쇼핑 (updated 19 Oct 2026) and Butler.
Income statement — chartable
Diluted EPS: no dilutive instruments were identified, so diluted EPS is assumed equal to basic; the separate diluted figure is n/d.
Margins (%) — chartable
Five-year compound growth (computed, FY2021→FY2025): revenue CAGR +4.6%; operating income CAGR +42.1%; net income CAGR +15.7%; EPS CAGR +15.3%.
Ten-year context — chartable: notes and sources
Source: ETF쇼핑 (DART annual reports, FY2016–FY2025): ### Quarterly results — chartable
Source: ETF쇼핑 compilation of DART quarterly, half-year and annual reports (filed 16 May 2024 to 14 Aug 2026). Quarterly sums reconcile to annual totals within rounding.
Trailing twelve months to 30 Jun 2026 (computed from the table above): revenue KRW 100.8 bn; operating income KRW 10.6 bn; net income KRW 6.4 bn; EPS about KRW 181 (matches Investing.com's TTM EPS of KRW 181). H1 FY2026 revenue was KRW 50.3 bn against KRW 50.4–50.5 bn in H1 FY2025 (IB Tomato cites KRW 50.3 bn vs KRW 50.5 bn).
Balance sheet
The latest available snapshot follows.
Debt trajectory. Simply Wall St reports that debt-to-equity fell from 27.6% to 4.4% over the five years to mid-2026. Operating cash flow covered debt about 2.5 times (254.9%), and the company earned more interest than it paid.
Commentary: trends, inflections and drivers
Revenue: a decade-long plateau, one step-change, then drift. Revenue was flat at KRW 84–86 bn for six years (FY2016–FY2021). This despite the 2018 Janghang expansion, whose ramp-up IBK Securities described in 2019 as slower than expected and still weighted to mid-to-low-priced products. The FY2022 step-up (+17.6%) coincided with the 2022 surge in grain prices. That surge pushed feed prices up industry-wide, and Daejoo was traded as a "grain theme" stock at the time. Some of the FY2022–FY2024 revenue gain was therefore likely price pass-through rather than volume. FY2025 revenue fell 4.8%, and H1 FY2026 was flat year on year. Volume growth is constrained by Janghang running at 159% of nameplate capacity, and livestock feed is in structural decline.
Gross margin: the central story. Gross margin rose from a trough of 14.8% (FY2019) to 25.2% (FY2025). Cost of sales fell from KRW 85.1 bn to KRW 75.5 bn between FY2023 and FY2025 even as revenue held at about KRW 100–106 bn. Three drivers appear to be at work: the mix shift to pet food (about 70% of feed revenue), easing grain costs after 2022, and the price premium of the newer premium SKUs. The 3Q FY2025 report attributed the improvement to higher-quality ingredients and an improved production structure (StockStalker summary). The company does not disclose a split of these drivers.
Operating leverage. Operating income quadrupled from KRW 2.6 bn to KRW 10.6 bn on only about 20% revenue growth. Personnel cost rose to 9.0% of parent revenue in FY2025 from 7.4% in FY2021, and headcount rose 12.6% in FY2025 (159 to 179). This suggests an investment in sales and marketing or production staff, but SG&A was nonetheless absorbed by the gross-margin gains.
Net income: volatile versus operating income. Net income exceeded operating income in FY2021 (KRW 3.8 bn vs KRW 2.6 bn) and FY2023 (KRW 10.1 bn vs KRW 7.7 bn). It fell well below operating income in 4Q FY2025 (KRW 1.0 bn vs KRW 3.5 bn). Simply Wall St flagged possible earnings-quality issues after the FY2023 result. Non-operating items are not itemised in accessed sources. The FY2024–FY2025 machinery disposals (about KRW 5 bn at cost) are a plausible source of the 4Q FY2025 non-operating charge, but this is not confirmed.
Balance sheet: conservative and asset-rich. Debt of KRW 5.0 bn against KRW 21.7 bn of cash leaves the company net cash. Equity of KRW 114.1 bn is anchored by land: the two plant sites carry KRW 77.9 bn at book value, 53% of total assets (computed).
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Group Entities
| Entity | Relationship | Activity | Source |
|---|---|---|---|
Daejoo Inc. (대주산업㈜) | Listed parent | Livestock feed (Incheon), pet food (Janghang), sales and brand ownership | DART via WiseReport |
Namjeon Mulsan (㈜남전물산) | 100% subsidiary, established by split in 2020 | Animal medicines | DART business section via StockStalker; WiseReport |
Kyungwon Nongsan (경원농산) | 20.54% investee | n/d (agricultural, by name) | DART FY2025 via ETF쇼핑 |
Other equity holdings (book value) | Minor investments | KT Corp. (0.0009%), Noksaek Gyeran (녹색계란), Korea Feed Hall (한국사료회관), Incheon professional football club (인천프로축구단), Korea Lottery (코리아로터리). Stakes and values n/d | DART FY2025 via ETF쇼핑 |
Segment Overview
| Segment | Contents | Share of revenue |
|---|---|---|
Feed (사료부문) | Livestock compound feed (cattle, pigs, poultry, duck, goat, deer, quail); dry and wet pet food and treats (Catsrang, Olive, Dograng, Shake-it Cat) | 99.35% |
Animal medicines (동물용의약품) | Namjeon Mulsan products | 6.76% |
Can (캔부문) | Canned products (likely wet pet food/snack cans; not specified) | 0.18% |
Intra-group eliminations (내부거래) | Sales between Daejoo and Namjeon Mulsan | −6.29% |
Revenue by Segment (%)
| Metric | FY2019 | FY2026 |
|---|---|---|
Pet food share of feed revenue (%) | 50 | 70 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansRevenue by Segment (%) (FY2016–H1 FY2026)
| Metric | FY2016 | H1 FY2026 |
|---|---|---|
Incheon plant utilisation, livestock feed (%) | 72.75 | 26.25 |
Janghang plant utilisation, pet food (%) | 241.75 | 158.75 |
Income Statement and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue (KRW Bn) | 84.4 | 99.2 | 105.0 | 106.0 | 101.0 |
Cost of sales (KRW Bn) | 71.3 | 83.2 | 85.1 | 81.1 | 75.5 |
Gross profit (KRW Bn) | 13.1 | 16.0 | 19.9 | 24.9 | 25.5 |
Operating income (KRW Bn) | 2.6 | 5.5 | 7.7 | 10.0 | 10.6 |
Net income (KRW Bn) | 3.8 | 4.3 | 10.1 | 8.3 | 6.8 |
EPS basic (KRW) | 108 | 123 | 287 | 235 | 191 |
Dividend per share (KRW) | 30 | 35 | 42 | 40 | 37 |
Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Gross margin (%) | 15.5 | 16.1 | 19.0 | 23.5 | 25.2 |
Operating margin (%) | 3.1 | 5.6 | 7.3 | 9.5 | 10.5 |
Net margin (%) | 4.5 | 4.4 | 9.7 | 7.8 | 6.7 |
Revenue growth YoY (%) | -0.9 | 17.6 | 5.8 | 1.0 | -4.8 |
Income Statement and Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | Source / note |
|---|---|---|---|---|---|---|
EBITDA (KRW Bn) | 4.8 | 7.6 | — | — | — | ETF쇼핑 publishes EBITDA through FY2022 only. TTM EBITDA as of Jul 2026: KRW 11.3 bn (MarketInOut); TradingView shows KRW 12.88 bn and a 13.32% margin (date of TTM window n/d) |
EBITDA margin (%) | 5.7 | 7.6 | — | — | — | ETF쇼핑 |
Dividends paid (KRW Bn) | 1.1 | 1.2 | 1.5 | 1.4 | 1.3 | ETF쇼핑 (dividend declared for each fiscal year) |
Payout ratio (%) | 28 | 29 | 15 | 17 | 19 | ETF쇼핑 |
Buybacks | 0 | 0 | 0 | 0 | 0 | ETF쇼핑 (no treasury-share purchases recorded) |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansIncome Statement and Margin Analysis (%) (FY2016–FY2025)
| Metric | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue (KRW Bn) | 85.1 | 85.5 | 84.1 | 84.3 | 85.2 | 84.4 | 99.2 | 105.0 | 106.0 | 101.0 |
Operating income (KRW Bn) | 3.2 | 3.6 | 3.4 | 2.7 | 4.5 | 2.6 | 5.5 | 7.7 | 10.0 | 10.6 |
Net income (KRW Bn) | 1.9 | 2.7 | 1.7 | 1.8 | 3.5 | 3.8 | 4.3 | 10.1 | 8.3 | 6.8 |
Gross margin (%) | 21.7 | 21.8 | 16.5 | 14.8 | 17.3 | 15.5 | 16.1 | 19.0 | 23.5 | 25.2 |
EPS (KRW) | 55 | 77 | 48 | 51 | 98 | 108 | 123 | 287 | 235 | 191 |
Financial Analysis
| Metric | 1Q24 | 2Q24 | 3Q24 | 4Q24 | 1Q25 | 2Q25 | 3Q25 | 4Q25 | 1Q26 | 2Q26 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue (KRW Bn) | 26.3 | 26.5 | 24.5 | 28.7 | 25.5 | 24.9 | 24.0 | 26.5 | 25.0 | 25.3 |
Operating income (KRW Bn) | 1.6 | 2.5 | 2.3 | 3.5 | 2.6 | 2.1 | 2.5 | 3.5 | 2.0 | 2.6 |
Net income (KRW Bn) | 2.0 | 1.8 | 2.0 | 2.5 | 2.0 | 1.9 | 1.9 | 1.0 | 1.6 | 1.9 |
Financial Analysis — Total assets
| Item (as of 30 Jun 2026) | KRW Bn | Source |
|---|---|---|
Total assets | 147.47 | Simply Wall St (S&P Global MI), H1 FY2026 |
Total liabilities | 33.37 | Same |
Total shareholders' equity | 114.10 | Same |
Total debt | 5.02 | Same |
Cash and short-term investments | 21.65 | Same |
Net cash (computed) | 16.63 | Cash less debt |
Current assets | 40.7 | Same |
Current liabilities | 14.7 | Same |
Non-current liabilities | 18.7 | Same |
Working capital (computed) | 26.0 | Current assets less current liabilities |
Incheon plant land (book value) | 73.8 | IB Tomato (DART H1 FY2026) |
Janghang plant land (book value) | 4.1 | IB Tomato (DART H1 FY2026) |
Financial Analysis — Free cash flow
| Item | Value | Period | Source |
|---|---|---|---|
Free cash flow | KRW 12.7 bn | FY2025 | ETF쇼핑 (DART) |
Operating cash flow | About KRW 12.8 bn (computed: 254.9% × KRW 5.02 bn debt) | TTM to Jun 2026 | Derived from Simply Wall St |
Machinery disposals (at acquisition cost) | FY2022: nil; FY2023: KRW 0.0246 bn; FY2024: about KRW 1.4 bn; FY2025: about KRW 3.6 bn | FY2022–FY2025 | IB Tomato (DART), Sep 2026 |
Dividends paid | KRW 1.3 bn | FY2025 declaration | ETF쇼핑 |
Buybacks | Nil | FY2016–FY2025 | ETF쇼핑 |
Financial Analysis — ROE
| Ratio | Value | Basis | Source |
|---|---|---|---|
ROE | 6.0% | FY2025 | ETF쇼핑 |
ROE (TTM) | 5.6%–5.8% | Mid/late 2026 | Butler; StockHub |
ROA | 4.6% | FY2025 | ETF쇼핑 |
ROIC | 7.58% | TTM Jul 2026 | MarketInOut |
Current ratio | 2.77x | 30 Jun 2026 (computed) | Simply Wall St inputs |
Debt / equity | 4.4% | 30 Jun 2026 | Simply Wall St |
Net debt / EBITDA | −1.47x (net cash) | Computed: (5.02 − 21.65) / 11.3 | Simply Wall St; MarketInOut |
Interest coverage | 36.5x | TTM Jul 2026 | MarketInOut |
Asset turnover | 0.68x | Computed: TTM revenue / assets at Jun 2026 | — |
Altman Z-score | 2.55 | Jul 2026 | MarketInOut |
Piotroski F-score | 6/9 | Jul 2026 | MarketInOut |
Share Price & Returns
| Period (to 20 Oct 2026 unless stated) | Return | Source |
|---|---|---|
1 month | +5.2% | ETF쇼핑 |
6 months | −54.7% | ETF쇼핑 |
1 year | +8.5% | ETF쇼핑 |
3 years (to 29 Jul 2026) | Total shareholder return −20% | Simply Wall St |
5 years | About −10% price change (computed: KRW 1,716 vs about KRW 1,915 on 6 Oct 2021 per Simply Wall St); dividends excluded | Computed |
52-week range | Close KRW 1,449–5,430 (ETF쇼핑); intraday KRW 1,355–6,090 (Investing.com) | ETF쇼핑; Investing.com |
Peak market cap (approx.) | KRW 162.8 bn at KRW 4,600 (30–31 Jan 2026) | Investing.com |
Capital Markets
| Metric | Daejoo | Woosung | Hanil Feed | Korea Industrial | OSP |
|---|---|---|---|---|---|
Market cap (KRW Bn) | 60.7 | 47.9 | 96.9 | 45.3 | 26.8 |
P/E (x) | 8.99 | 34.19 | 17.72 | 7.25 | n/m (loss) |
P/B (x) | 0.54 | 0.24 | 0.60 | — | 0.83 |
EV/EBITDA (x) | 3.9 | — | — | 5.59 | — |
EV/Sales (x) | 0.44 | — | — | 0.42 | — |
Dividend yield (%) | 2.16 | 8.38 | — | — | 0 |
Per-Share Data and Dividends & Capital Returns
| Metric | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Dividend per share (KRW) | 25 | 30 | 30 | 30 | 35 | 30 | 35 | 42 | 40 | 37 |
Total dividend (KRW Bn) | 0.9 | 1.1 | 1.1 | 1.1 | 1.2 | 1.1 | 1.2 | 1.5 | 1.4 | 1.3 |
Payout ratio (%) | 46 | 39 | 63 | 59 | 35 | 28 | 29 | 15 | 17 | 19 |
Analyst Conclusions
Management guidance. None published. The company holds no earnings calls and issues no guidance, and it did not respond to press enquiries in September 2026 (IB Tomato).
Consensus growth expectations. None (no coverage).
Run-rate indicators. TTM revenue of KRW 100.8 bn, operating income of KRW 10.6 bn and net income of KRW 6.4 bn (computed). 2Q FY2026 operating income rose 22.8% year on year after a 23.7% decline in 1Q, so H1 FY2026 operating income of KRW 4.6 bn is roughly flat against KRW 4.7 bn in H1 FY2025.
Bull case
-
Asset value floor with an operating business on top. The Incheon land book value of KRW 73.8 bn exceeds the KRW 60.7 bn market cap. Add KRW 16.6 bn of net cash and the market is effectively assigning a negative value to an operating business that earns about KRW 10.6 bn of operating income and generated KRW 12.7 bn of FCF in FY2025. Any credible plan to monetise the Incheon site, which is near the Seorim redevelopment, would crystallise this.
-
Margin durability from mix. Gross margin has risen for four consecutive years (16.1% → 25.2%), pet food is now about 70% of feed revenue, and premium SKUs (Vita+, Kitten, Weight Care, freeze-dried, Olive functional) were launched in 2025–2026. A further mix shift should be margin-accretive at roughly twice livestock-feed pricing.
-
Unmet demand. Janghang running at 159% of nameplate indicates demand above current capacity. Debt-free capacity expansion, funded from cash or Incheon proceeds, could restart revenue growth, and exports to 8+ countries add optionality.
Bear case
-
Growth has stalled, and the obvious fix is unannounced. Revenue has fallen 4.8% and stayed flat over six quarters. There is no capex plan, and machinery spending of about KRW 1.3 bn over two years is minimal. Without new pet-food capacity, earnings are capped near KRW 10–11 bn of operating income.
-
Land value is not the shareholders' value. The owner-CEO controls 36%, the board has a minority of independent directors, and payout has fallen to about 19%. There is no disclosed intent to sell or redevelop Incheon, and the plant still operates. The "asset discount" has persisted for years and may continue indefinitely.
-
Theme-driven price risk. The stock rose about 160% and then fell about 72% within a year on political narratives unrelated to fundamentals: Sejong relocation in 2011, 2020 and 2025, and Jung Won-oh in 2025–2026. Liquidity and price can decouple violently from operations. With no analyst coverage and minimal disclosure, the price may continue to respond more to speculative flows than to fundamentals.
Key catalysts and monitorables (next 12 months)
| Monitorable | Why it matters | Expected timing |
|---|---|---|
| 3Q FY2026 quarterly report | Confirms whether the 2Q margin rebound holds; tests revenue trend | By 14 Nov 2026 |
| FY2026 dividend decision | Signals whether payout rises from about 19% | About late Feb 2027 |
| FY2026 annual report | Segment detail, capex, machinery disposals, any land revaluation | About mid-Mar 2027 |
| Any capex or capacity announcement for pet food | Determines growth trajectory | Unscheduled |
| Incheon site: zoning, redevelopment or sale news | Unlocks asset value | Unscheduled |
| Grain prices (corn, soybean meal) and KRW/USD | Main gross-margin variable | Ongoing |
| Further insider purchases by the CEO | Signals owner confidence or creeping consolidation | Ongoing |
| KRX market-warning designations or renewed political-theme trading | Volatility and reputational risk | Event-driven |
| Export traction after Taipei | Validates the overseas channel | FY2026–FY2027 |
Concluding analyst verdict
Daejoo Inc. is two businesses and an asset in one listed shell. The first business is a profitable, mid-market cat-food franchise. Catsrang has two decades of brand equity and was ranked No. 2 in Korean cat food by Euromonitor. It has moved the group's gross margin from the mid-teens to 25% and its operating margin to 10.5%, the best among listed Korean feed peers. The second business is a legacy livestock-feed mill in Incheon that runs at about a quarter of capacity in a shrinking, consolidated market. The asset is the land under that mill, booked at KRW 73.8 bn, more than the company's entire current market value.
The financial profile is sound: about KRW 101 bn of revenue, about KRW 10.6 bn of operating income, KRW 12.7 bn of FY2025 free cash flow, net cash, and leverage that has fallen steadily. Valuation looks optically low, at about 9x trailing earnings, 0.54x book and an EV/EBITDA of about 4x (computed).
The discount has clear causes. Growth has stopped because the only pet-food plant is running far above nameplate and no expansion has been announced. Disclosure is minimal, there is no analyst coverage, and the company declines to comment on restructuring. Control rests with an owner-CEO who is buying stock while the payout ratio has drifted down to about 19%. The share price has been repeatedly captured by political-theme speculation and has round-tripped from about KRW 2,200 to an intraday high of KRW 6,090 and back to about KRW 1,700 inside a year. That reflects the shareholder base, not the business.
On the evidence, Daejoo is a deep-value, governance-contingent situation rather than a growth story. The upside case requires a management decision, either to add pet-food capacity or to monetise Incheon, that has not been signalled. Until one is, the most defensible characterisation is a stable, cash-generative niche brand trading below asset value, with high non-fundamental price risk and limited visibility.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Title | Compensation | Source |
|---|---|---|---|
Jung Seok-won (정석원) | Representative Director (CEO); largest shareholder | Not individually disclosed (below the KRW 500 M individual-disclosure threshold) | ETF쇼핑 (DART FY2025); WiseReport |
Outside (independent) directors | 2 of 6 board members (per Simply Wall St, 2022) | — | Simply Wall St board-change notes, Apr and Nov 2022 |
Major Shareholders
| Holder | Shares | Stake | Date | Source |
|---|---|---|---|---|
Jung Seok-won (CEO), with no listed related parties | 12,741,431 | 36.00% | 14 Aug 2026 | WiseReport |
Jung Seok-won (CEO) | — | 35.83% | 31 Dec 2022–31 Dec 2025 | ETF쇼핑 (DART) |
Largest shareholder and related parties | — | 38.37% | 31 Dec 2021 | ETF쇼핑 (DART) |
Minority shareholders (25,957 holders) | — | 64.17% | 31 Dec 2025 | ETF쇼핑 (DART) |
Foreign investors | — | 3.35% | Apr 2026 | Korea IR Council AI report |
Float | 22.66 M shares | — | Jul 2026 | MarketInOut |
Competitive Landscape
Key Competitors
| Competitor | Owner / type | Positioning vs Daejoo | Data point | Source |
|---|---|---|---|---|
Royal Canin | Mars (global) | No. 1 in both the Korean dog and cat food markets (2021); premium and veterinary channel | Market leader | Euromonitor via DailyVet, 2022 |
Ciao Churu | Inaba (Japan) | No. 3 cat food brand in 2021 (treats) | Strong in snacks | Same |
Harim Pet Food | Harim Group (Korea) | Domestic premium challenger; No. 6 cat, No. 7 dog brand in 2021 | Rising domestic premium | Same |
Natural Core | Korean | No. 2 dog food brand in 2021 | Dog-focused | Same |
ANF | Korean brand | No. 3 dog, No. 8 cat in 2021 | Mid-premium | Same |
Natural Balance | US brand | No. 7 cat in 2021 | Imported premium | Same |
Nutro, Whiskas | Mars | No. 9 and No. 10 cat in 2021 | Global mass/premium | Same |
Wooriwa | Korean | Ranked No. 1 in the overall dog-and-cat market in a 2020 Euromonitor dataset | Mass market | DailyVet (Euromonitor 2020) |
Coupang private label | Coupang (Korea) | No. 8 in cat food in 2020 | Online price competition | DailyVet (Euromonitor 2020) |
OSP (오에스피, KOSDAQ 368970) | Listed; subsidiary of Woojin B&G | Organic pet-food ODM with more than 50% of Korean organic pet-food production; own brand INDIGO | FY2025 revenue KRW 25.4 bn; operating loss KRW 1.3 bn | Butler; ValueLine; NICE report |
Daehan Jedang (Welz) | TS Corp. | Organic premium pet food | Revenue n/d | Theme-stock blogs (low reliability) |
Key Competitors (Annual)
| Competitor | Type | FY2025 revenue (KRW Bn) | FY2025 operating income (KRW Bn) | Source |
|---|---|---|---|---|
Farmsco | Large integrated feed and livestock producer | About 1,498.5 (fiscal year not specified) | — | Jasoseol (public data) |
Woosung (우성, KOSPI 006980) | Listed feed maker | 613.0 | 19.4 | Butler |
Hanil Feed (한일사료, KOSDAQ 005860) | Feed plus meat distribution (feed is the minority of revenue; meat distribution 66.3%) | 454.9 | 5.9 | Korea IR Council AI report; Bullstory (OpenDART) |
Korea Industrial (고려산업, 002140) | Busan-based feed maker | 297.3 | 13.7 | Bullstory (OpenDART) |
Cargill Agri Purina | Global (unlisted in Korea) | n/d. Dangjin plant built for 870,000 t/year | — | CCM, 2012 |
NACF (Nonghyup) Feed | Cooperative | — | — | — |
CJ, Sunjin, Easy Bio, Hyundai Feed | Domestic feed groups | n/d in accessed sources | — | — |
Peer Comparison FY2026
| Metric | Daejoo | Woosung | Korea Industrial | Hanil Feed | OSP |
|---|---|---|---|---|---|
Revenue (KRW Bn) | 101.0 | 613.0 | 297.3 | 454.9 | 25.4 |
Revenue growth YoY (%) | -4.8 | 1.1 | — | 5.5 | -16.2 |
Operating income (KRW Bn) | 10.6 | 19.4 | 13.7 | 5.9 | -1.3 |
Operating margin (%) | 10.5 | 3.2 | 4.6 | 1.3 | -5.1 |
Net income (KRW Bn) | 6.8 | 12.9 | 9.7 | 6.2 | -3.3 |
Net margin (%) | 6.7 | 2.1 | 3.3 | 1.4 | -13.0 |



